Wendy Marder

ORCID: 0000-0001-7963-4206 · 3 papers in corpus
observational 2025
Arthritis & rheumatology (Hoboken, N.J.) ·doi:10.1002/art.70042

OBJECTIVE: Nociplastic pain is pain primarily driven by the central nervous system and, unlike nociceptive pain conditions, is thought to be refractory to peripherally directed therapies. Nociplastic pain is also associated with hypersensit…

review 2012
Clinical medicine insights. Reproductive health ·doi:10.4137/cmrh.s10415

Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency(POI) due to gonadotoxicity of this therapy. In addition to loss of rep…

nonrandomized-trial 2005
Arthritis and rheumatism ·doi:10.1002/art.21263

OBJECTIVE: Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study…